2025 HAE International (HAEi) Regional Conference EMEA
Oct 10 - Oct 12, 2025
- Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Results of the CHAPTER-1 Open-Label Extension Study
Presenter: Mauro Cancian, M.D., Ph.D.
Format: Poster Presentation
Date, Time: Friday, October 10, 6:35 p.m. CET (12:35 p.m. ET) - Title: Long-Term Prophylactic Treatment with Oral Deucrictibant Improved Health-Related Quality of Life and Disease Control in Participants with Hereditary Angioedema: CHAPTER-1 Open-Label Extension Study
Presenter: Andrea Zanichelli, M.D., Ph.D.
Format: Poster Presentation
Date, Time: Friday, October 10, 6:35 p.m. CET (12:35 p.m. ET) - Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
Presenter: Anna Valerieva, M.D., Ph.D.
Format: Poster Presentation + Short Talk
Date, Time: Friday, October 10, 6:35 p.m. CET (12:35 p.m. ET) - Title: Durability of Response to a Single Dose of Oral Deucrictibant for On-Demand Treatment of Hereditary Angioedema Attacks
Presenter: Markus Magerl, M.D.
Format: Poster Presentation
Date, Time: Friday, October 10, 6:35 p.m. CET (12:35 p.m. ET) - Title: Efficacy and Safety of Oral Deucrictibant for Prophylaxis and On-Demand Treatment of Attacks in Acquired Angioedema with C1 Inhibitor Deficiency: CREAATE Phase 3 Trial Design
Presenter: Danny M. Cohn, M.D., Ph.D.
Format: Poster Presentation
Date, Time: Friday, October 10, 6:35 p.m. CET (12:35 p.m. ET) - Title: Clinical Validation of a Novel Biomarker Assay to Characterize Bradykinin-Mediated Angioedema in Prospective and Biobank Plasma Samples
Presenter: Henriette Farkas, M.D., Ph.D., D.Sc.
Format: Oral Presentation
Date, Time: Saturday, October 11, 9:45 a.m. CET (3:35 a.m. ET)